Ropes & Gray To Investigate GSK Bribery Scandal In China

Law360, Washington (July 24, 2013, 4:44 PM ET) -- GlaxoSmithKline PLC has hired the international law firm Ropes & Gray LLP to conduct an independent review investigating a bribery corruption scandal in which Chinese officials allege senior executives paid physicians and hospitals to boost drug sales, a spokeswoman confirmed Wednesday.

Although GSK and Ropes & Gray declined to disclose any information about the upcoming investigation, the pharmaceutical company has repeatedly affirmed that it will eliminate any corruption it finds and is committed to cooperating with the Chinese officials' probe as well.

The news came as...
To view the full article, register now.